[NBIX] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
06-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- 10.00%
YoY- 136.63%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 247,900 258,500 302,400 237,100 244,100 222,094 183,580 22.05%
PBT 41,700 -57,100 83,200 38,900 38,600 58,407 52,091 -13.72%
Tax -306,200 500 3,600 1,500 4,600 4,618 753 -
NP 347,900 -57,600 79,600 37,400 34,000 53,789 51,338 256.03%
Tax Rate 734.29% - -4.33% -3.86% -11.92% -7.91% -1.45% -
Total Cost -100,000 316,100 222,800 199,700 210,100 168,305 132,242 -
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 140.34 -22.28 26.32 15.77 13.93 24.22 27.96 191.72%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS 3.72 -0.62 0.86 0.40 0.37 0.59 0.56 251.35%
EPS Diluted 3.58 -0.62 0.81 0.39 0.35 0.56 0.54 250.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.